Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
BrightView Holdings
BV
$1.22B
| $373K | ﹤0.01% |
23,170
-11,023
| -32% | -$194K |
|
3202
Citizens
CIA
$235M
| $373K | ﹤0.01% |
70,285
+28,840
| +70% | +$159K |
|
|
ARGO
3203
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $373K | ﹤0.01% |
7,201
-22,666
| -76% | -$1.22M |
|
3204
PUT
CoreCivic
CXW
$2.98B
| $371K | ﹤0.01% |
35,400
| – | – |
|
3205
Sprott Physical Gold
PHYS
$14.7B
| $371K | ﹤0.01% |
26,445
| – | – |
|
3206
Stoke Therapeutics
STOK
$1.97B
| $370K | ﹤0.01% |
11,013
-6,634
| -38% | -$235K |
|
3207
PUT
Bausch Health
BHC
$2.41B
| $369K | ﹤0.01% |
12,600
| – | – |
|
|
GGN
3208
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$773M
| $369K | ﹤0.01% |
92,243
-61,410
| -40% | -$239K |
|
|
GLDD
3209
DELISTED
Great Lakes Dredge & Dock
GLDD
| $368K | ﹤0.01% |
25,121
-50,428
| -67% | -$745K |
|
3210
Resources Connection
RGP
$158M
| $368K | ﹤0.01% |
25,651
-12,881
| -33% | -$186K |
|
3211
Red Rock Resorts
RRR
$3.76B
| $368K | ﹤0.01% |
8,664
-47,225
| -84% | -$1.87M |
|
3212
Towne Bank
TOWN
$3.53B
| $368K | ﹤0.01% |
12,117
-51,306
| -81% | -$1.61M |
|
|
TBNK
3213
DELISTED
Territorial Bancorp Inc.
TBNK
| $367K | ﹤0.01% |
14,132
-6,027
| -30% | -$155K |
|
|
GOLD
3214
Gold.com Inc
GOLD
$1.24B
| $366K | ﹤0.01% |
15,752
-1,638
| -9% | -$36.6K |
|
3215
UFP Technologies
UFPT
$2.59B
| $366K | ﹤0.01% |
6,375
-1,476
| -19% | -$80.2K |
|
3216
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
| $365K | ﹤0.01% |
3,430
| – | – |
|
|
BHR
3217
Braemar Hotels & Resorts
BHR
$144M
| $364K | ﹤0.01% |
58,543
-47,995
| -45% | -$296K |
|
3218
Columbia Financial
CLBK
$1.12B
| $364K | ﹤0.01% |
21,141
-27,912
| -57% | -$492K |
|
3219
Vuzix
VUZI
$220M
| $364K | ﹤0.01% |
19,821
-26,505
| -57% | -$535K |
|
3220
PC Connection
CNXN
$2.19B
| $363K | ﹤0.01% |
7,859
-9,798
| -55% | -$459K |
|
3221
Gorman-Rupp
GRC
$2.26B
| $363K | ﹤0.01% |
10,528
-10,588
| -50% | -$368K |
|
3222
Rhythm Pharmaceuticals
RYTM
$7.26B
| $363K | ﹤0.01% |
18,488
-55,795
| -75% | -$1.16M |
|
3223
State Street SPDR NYSE Technology ETF
XNTK
$2.22B
| $363K | ﹤0.01% |
+2,283
| New | +$342K |
|
3224
Hyatt Hotels
H
$16.4B
| $362K | ﹤0.01% |
4,657
-108,599
| -96% | -$8.78M |
|
3225
Adams Diversified Equity Fund
ADX
$3.19B
| $360K | ﹤0.01% |
+15,664
| New | +$301K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.